Screener
LB Pharmaceuticals Inc LBRX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Total current assets | 389,074 | 308,432 |
| Operating lease right-of-use assets, net | 2,101 | 2,151 |
| Property and equipment, net | 1,531 | 1,581 |
| Restricted cash | 776 | 770 |
| Total assets | $393,482 | $312,934 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $7,119 | $2,127 |
Item 1. Financial Statements
FAQ
- What is LB Pharmaceuticals Inc's restricted cash?
- LB Pharmaceuticals Inc (LBRX) reported restricted cash of $776K in Q1 2026.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about LB Pharmaceuticals Inc's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude